Table 3 Frequency of comorbidities in patients with confirmed Middle East respiratory syndrome coronavirus
From: Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study
Comorbidities | Patients |
|---|---|
Diabetes mellitus | 60 (31.6) |
Hypertension | 54 (28.4) |
B. asthma | 18 (9.5) |
IHD | 11 (5.8) |
CHF | 5 (2.6) |
End-stage renal disease | 5 (2.6) |
Pneumonia | 4 (2.1) |
Hypothyroidism | 4 (2.1) |
CVA | 3 (1.6) |
Liver cirrhosis | 2 (1.1) |
HF | 1 (0.5) |
BPH | 1 (0.5) |
Hodgkin’s lymphoma | 1 (0.5) |
Chronic obstructive pulmonary disease | 1 (0.5) |
Sickle cell anemia | 1 (0.5) |
Liver carcinoma | 1 (0.5) |
Mitral + aortic valve replacement | 1 (0.5) |
Acute respiratory distress syndrome | 1 (0.5) |
Chronic kidney disease | 1 (0.5) |
Tuberculosis | 1 (0.5) |
RF | 1 (0.5) |
CP | 1 (0.5) |
COPC | 1 (0.5) |
Lung cancer | 1 (0.5) |
Anemia | 1 (0.5) |
Gout | 1 (0.5) |
Myeloma | 1 (0.5) |
None | 82 (43.2) |